c-Jun Overexpression Accelerates Wound Healing in Diabetic Rats by Human Umbilical Cord-Derived Mesenchymal Stem Cells

Objective Mesenchymal stem cells (MSCs) are considered a promising therapy for wound healing. Here, we explored the role of c-Jun in diabetic wound healing using human umbilical cord-derived MSCs (hUC-MSCs). Methods Freshly isolated hUC-MSCs were subjected to extensive in vitro subcultivation. The cell proliferative and migratory capacities were assessed by the Cell Counting Kit-8 and scratch assays, respectively. c-Jun expression was evaluated by RT-PCR and western blot analysis. The function of c-Jun was investigated with lentivirus transduction-based gene silencing and overexpression. Diabetes mellitus was induced in SD rats on a high-glucose/fat diet by streptozocin administration. Wounds were created on the dorsal skin. The effects of c-Jun silencing and overexpression on wound closure by hUC-MSCs were examined. Reepithelialization and angiogenesis were assessed by histological and immunohistochemical analysis, respectively. Platelet-derived growth factor A (PDGFA), hepatocyte growth factor (HGF), and vascular endothelial growth factor (VEGF) levels were determined by western blot analysis. Results hUC-MSCs showed gradually decreased cell proliferation, migration, and c-Jun expression during subcultivation. c-Jun silencing inhibited cell proliferation and migration, while c-Jun overexpression enhanced proliferation but not migration. Compared with untransduced hUC-MSCs, local subcutaneous injection of c-Jun-overexpressing hUC-MSCs accelerated wound closure, enhanced angiogenesis and reepithelialization at the wound bed, and increased PDGFA and HGF levels in wound tissues. Conclusion c-Jun overexpression promoted hUC-MSC proliferation and migration in vitro and accelerated diabetic wound closure, reepithelization, and angiogenesis by hUC-MSCs in vivo. These beneficial effects of c-Jun overexpression in diabetic wound healing by hUC-MSCs were at least partially mediated by increased PDGFA and HGF levels in wound tissues.

[1]  Priscilla Barros Delben,et al.  In vitro comparative study of human mesenchymal stromal cells from dermis and adipose tissue for application in skin wound healing , 2019, Journal of tissue engineering and regenerative medicine.

[2]  Huiyong Shen,et al.  Characterization and Therapeutic Application of Mesenchymal Stem Cells with Neuromesodermal Origin from Human Pluripotent Stem Cells , 2019, Theranostics.

[3]  F. Wang,et al.  Mesenchymal Stem Cells Coated by the Extracellular Matrix Promote Wound Healing in Diabetic Rats , 2019, Stem cells international.

[4]  Brian Fury,et al.  Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions , 2018, Transfusion.

[5]  S. Son,et al.  In vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse model , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Xiaobing Fu,et al.  Platelet-derived growth factor receptor beta identifies mesenchymal stem cells with enhanced engraftment to tissue injury and pro-angiogenic property , 2018, Cellular and Molecular Life Sciences.

[7]  Hui Wang,et al.  Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer , 2017, Oncotarget.

[8]  A. de Klein,et al.  Aging of bone marrow- and umbilical cord-derived mesenchymal stromal cells during expansion. , 2017, Cytotherapy.

[9]  S. Brennecke,et al.  Native and solubilized decellularized extracellular matrix: A critical assessment of their potential for improving the expansion of mesenchymal stem cells. , 2017, Acta biomaterialia.

[10]  J. Zhao,et al.  SRT1720 promotes survival of aged human mesenchymal stem cells via FAIM: a pharmacological strategy to improve stem cell-based therapy for rat myocardial infarction , 2017, Cell Death & Disease.

[11]  Lan Xiao,et al.  c-Jun enhances intestinal epithelial restitution after wounding by increasing phospholipase C-γ1 transcription. , 2017, American journal of physiology. Cell physiology.

[12]  L. Griffith,et al.  Epidermal Growth Factor Tethered to β-Tricalcium Phosphate Bone Scaffolds via a High-Affinity Binding Peptide Enhances Survival of Human Mesenchymal Stem Cells/Multipotent Stromal Cells in an Immune-Competent Parafascial Implantation Assay in Mice , 2016, Stem cells translational medicine.

[13]  V. Falanga,et al.  Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy. , 2016, Advances in wound care.

[14]  C. Hellweg,et al.  Transcription Factors in the Cellular Response to Charged Particle Exposure , 2016, Front. Oncol..

[15]  A. Izeta,et al.  Amniotic Membrane Modifies the Genetic Program Induced by TGFß, Stimulating Keratinocyte Proliferation and Migration in Chronic Wounds , 2015, PloS one.

[16]  S. Wong,et al.  Pericytes, mesenchymal stem cells and their contributions to tissue repair. , 2015, Pharmacology & therapeutics.

[17]  Shinn-Zong Lin,et al.  Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy , 2015, Cell transplantation.

[18]  M. Loda,et al.  c‐Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas , 2014, The Journal of pathology.

[19]  K. Kang,et al.  Sargahydroquinoic acid inhibits TNFα-induced AP-1 and NF-κB signaling in HaCaT cells through PPARα activation. , 2014, Biochemical and biophysical research communications.

[20]  R. Christensen,et al.  Mesenchymal stem cells, cancer challenges and new directions. , 2014, European journal of cancer.

[21]  N. Kaminski,et al.  Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response. , 2014, American journal of respiratory and critical care medicine.

[22]  Kevin Woo,et al.  Diabetic foot ulcers: Part I. Pathophysiology and prevention. , 2014, Journal of the American Academy of Dermatology.

[23]  W. Zeng,et al.  Neurotrophin-3 Accelerates Wound Healing in Diabetic Mice by Promoting a Paracrine Response in Mesenchymal Stem Cells , 2013, Cell transplantation.

[24]  A. Behrens,et al.  Arginine methylation of the c‐Jun coactivator RACO‐1 is required for c‐Jun/AP‐1 activation , 2013, The EMBO journal.

[25]  M. Heur,et al.  Interleukin‐1β enhances cell migration through AP‐1 and NF‐κB pathway‐dependent FGF2 expression in human corneal endothelial cells , 2013, Biology of the cell.

[26]  S. Hsiao,et al.  Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. , 2012, Stem cells and development.

[27]  Meiling Zhang,et al.  Improved refractory wound healing with administration of acidic fibroblast growth factor in diabetic rats. , 2011, Diabetes research and clinical practice.

[28]  N. Gibran,et al.  Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. , 2010, Experimental cell research.

[29]  N. Gibran,et al.  Mesenchymal stem cells induce dermal fibroblast responses to injury. , 2010, Experimental cell research.

[30]  Hiroyuki Miyoshi,et al.  The Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair , 2009, Science.

[31]  Roland Eils,et al.  AP-1-controlled hepatocyte growth factor activation promotes keratinocyte migration via CEACAM1 and urokinase plasminogen activator/urokinase plasminogen receptor. , 2009, The Journal of investigative dermatology.

[32]  J. Brandner,et al.  Biphasic regulation of AP-1 subunits during human epidermal wound healing. , 2007, The Journal of investigative dermatology.

[33]  J. McCarthy,et al.  Common infections in diabetes: pathogenesis, management and relationship to glycaemic control , 2007, Diabetes/metabolism research and reviews.

[34]  Horng-mo Lee,et al.  Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. , 2006, Journal of biomedical science.

[35]  E. Wagner,et al.  MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence , 2004, Nature Cell Biology.

[36]  R. Grose.  Epithelial migration: open your eyes to c-Jun , 2003, Current Biology.

[37]  J. Arbeit,et al.  c-Jun is essential for organization of the epidermal leading edge. , 2003, Developmental cell.

[38]  育梅.  Effects of dominant-negative c-Jun on platelet-derived growth factor-induced vascular smooth muscle cell proliferation , 2003 .

[39]  Shokei Kim,et al.  Effects of Dominant‐Negative c‐Jun on Platelet‐Derived Growth Factor‐Induced Vascular Smooth Muscle Cell Proliferation , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[40]  E. Wagner,et al.  The Mammalian UV Response c-Jun Induction Is Required for Exit from p53-Imposed Growth Arrest , 2000, Cell.

[41]  N. Fusenig,et al.  c-Jun and JunB Antagonistically Control Cytokine-Regulated Mesenchymal–Epidermal Interaction in Skin , 2000, Cell.

[42]  E. Wagner,et al.  Control of cell cycle progression by c-Jun is p53 dependent. , 1999, Genes & development.

[43]  R. Johnson,et al.  c‐Jun regulates cell cycle progression and apoptosis by distinct mechanisms , 1999, The EMBO journal.

[44]  B. Cronstein,et al.  Wound Healing Is Accelerated by Agonists of Adenosine A2 (Gα s-linked) Receptors , 1997, The Journal of experimental medicine.

[45]  S. Goldstein.  Cellular and molecular biological studies on diabetes mellitus. , 1984, Pathologie-biologie.